Matsuzaki Yuriko - My portal

Profile Information

J-GLOBAL ID: 200901038492478054
researchmap Member ID: 5000067727

Research Interests

tumor medaka

Research Areas

Life sciences / Tumor biology /

Education

Apr, 1981 - Mar, 1983

Biology, Science, Tokyo Metropolitan University

Papers

Establishment of pten knockout medaka with transcription activator-like effector nucleases (TALENs) as a model of PTEN deficiency disease

Yuriko Matsuzaki, Tetsushi Sakuma, Takashi Yamamoto, Hideyuki Saya

PLOS ONE, 12(10), Oct, 2017 Peer-reviewed
Establishment of HRASG12V Transgenic Medaka as a Stable Tumor Model for In Vivo Screening of Anticancer Drugs

Yuriko Matsuzaki, Haru Hosokai, Yukiyo Mizuguchi, Shoji Fukamachi, Atsushi Shimizu, Hideyuki Saya

PLoS ONE, 8(1), Jan 14, 2013 Peer-reviewed
Reversible whole-organism cell cycle arrest in a living vertebrate

Oltea Sampetrean, Shin-ichi Iida, Shinji Makino, Yuriko Matsuzaki, Kikuo Ohno, Hideyuki Saya

CELL CYCLE, 8(4) 620-627, Feb, 2009 Peer-reviewed
Identification of a novel cancer-testis antigen calreticulin2 (CRT2) frequently expressed in melanoma

Tomonori Yaguchi, Emiko Hayashi, Go Hasegawa, Tomonobu Fujita, Toshiro Kageshita, Makoto Sano, Yuriko Matsuzaki, Yutaka Kawakami

PIGMENT CELL & MELANOMA RESEARCH, 21(2) 272-273, Apr, 2008 Peer-reviewed
A new melanoma antigen FABP7 is a potential target for diagnosis, immunotherapy, and molecular target therapy

Goto, Y, Matsuzaki, Y, Murata, H, Takata, M, Aburatani, H, Hoon, D, Saida, T, Kawakami, Y

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 128 S211-S211, Apr, 2008 Peer-reviewed
Dendritic cells transduced with autoantigen FCRLA induce cytotoxic lymphocytes and vaccinate against murine B-Cell lymphoma

Takashi Inozume, Hiroshi Mitsui, Takashi Okamoto, Yuriko Matsuzaki, Yutaka Kawakami, Naotaka Shibagaki, Shinji Shimada

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 127(12) 2818-2822, Dec, 2007 Peer-reviewed
Identification of a novel cancer-testis antigen CRT2 frequently expressed in various cancers using representational differential analysis

Emiko Hayashi, Yuriko Matsuzaki, Go Hasegawa, Tomonori Yaguchi, Sachiko Kurihara, Tomonobu Fujita, Toshiro Kageshita, Makoto Sano, Yutaka Kawakami

CLINICAL CANCER RESEARCH, 13(21) 6267-6274, Nov, 2007 Peer-reviewed
Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease

S Otani, T Sakurai, K Yamamoto, T Fujita, Y Matsuzaki, Y Goto, Y Ando, S Suzuki, M Usui, M Takeuchi …

BRITISH JOURNAL OF OPHTHALMOLOGY, 90(6) 773-777, Jun, 2006 Peer-reviewed
A new melanoma antigen fatty acid-binding protein 7, involved in proliferation and invasion, is a potential target for immunotherapy and molecular target therapy

Y Goto, Y Matsuzaki, S Kurihara, A Shimizu, T Okada, K Yamamoto, H Murata, M Takata, H Aburatani, DSB Hoon …

CANCER RESEARCH, 66(8) 4443-4449, Apr, 2006 Peer-reviewed
A novel cancer testis antigen frequently expressed in pancreatic, lung and endometrial cancers

Okada T, Akada M, Fujita T, Iwata T, Goto Y, Kido K, Okada T, Matsuzaki Y, Kobayashi K, Matsuno S …

Clinical Cancer Research, 12(1) 191-197, Jan 1, 2006 Peer-reviewed
Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis.

Okada Takaho, Noji Shinobu, Goto Yasufumi, Iwata Takashi, Fujita Tomonobu, Okada Tsutomu, Matsuzaki Yuriko, Kuwana Masataka, Hirakata M, Horii A …

International Journal of Cancer, 116(6) 925-933, Oct, 2005 Peer-reviewed
Novel melanoma antigen, FCRL/FREB, identified by cDNA profile comparison using DNA chip are immunogenic in multiple melanoma patients.

Inozume Takashi, Matsuzaki Yuriko, Kurihara Sachiko, Fujita Tomonobu, Yamamoto Akifumi, Aburatani Hiroyuki, Shimada Shinji, Kawakami Yutaka

International Journal of Cancer, 114 283-290, 2005 Peer-reviewed
Immunological detection of altered signaling molecules involved in melanoma development.

Kawakami Yutaka, Sumimoto Hidetoshi, Fujita Tomonobu, Matsuzaki Yuriko

Cancer Metastasis and Rev, 24 357-366, 2005 Peer-reviewed
Frequent immune responses to a cancer/testis antigen,CAGE,in patients with microsatellite instability positive endometrial cancer

Iwata Takashi, Fujita Tomonobu, Hirao Nobumaru, Matsuzaki Yuriko, Okada Tsutomu, Mochimaru Hiroshi, Susumu N, Matsumoto E, Sugano K, Yamashita N …

Clinical Cancer Res., 11 3949-3957, 2005 Peer-reviewed
Systematic identification of human melanoma antigens using serial analysis of gene expression (SAGE).

Matsuzaki Yuriko, Hashimoto Shin-ichi, Fujita Tomonobu, Suzuki Takuji, Sakurai Toshiharu, Matsushima Kouji, Kawakami Yutaka

Journal Immunother, 28 39374, Jan, 2005 Peer-reviewed
Identification of novel bladder cancer antigen, human lipoic acid synthetase, recoginized by antibodis in serum of a patient with metastatic bladder cancer.

Ito Keiichi, Fujita Tomonobu, Akada Masanori, Kiniwa Yukiko, Tsukamoto Makoto, Yamamoto Aiko, Matsuzaki Yuriko, Matsushita Maiko, Asano Takako, Nakamura Jun …

International Journal of Cancer, 108 712-724, 2004 Peer-reviewed
Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma

Kiniwa Yukiko, Fujita Tomonobu, Akada M, Ito Keiich, Shofuda Tomoko, Suzuki Yuriko, Yamamoto Akifumi, Saida Toshiaki, Kawakami Yutaka

Cancer Research, 61(21) 7900-7907, Nov, 2001 Peer-reviewed
T cell immune responses against melanoma and melanocytes in cancer and autoimmunity

Kawakami Yutaka, Suzuki Yuriko, Shofuda Tomoko, Kiniwa Yukiko, Inozume Takashi, Dan Katsuaki, Sakurai Toshiharu, Fujita Tomonobu

Pigment Cell Research, 13(Suppl 8) 163-169, 2000 Peer-reviewed
Transcription initiation mediated by initiator binding protein in Saccharomyces cerevisiae

Ohishi-shofuda Tomoko, Suzuki Yuriko, Yano Ken-ichi, Sakurai Hiroshi, Fukasawa Toshio

Biochemical and Biophysical Research Communications, 255(1) 157-163, Feb, 1999 Peer-reviewed
THE YEAST GAL11 PROTEIN IS INVOLVED IN REGULATION OF THE STRUCTURE AND THE POSITION EFFECT OF TELOMERES

Y SUZUKI, M NISHIZAWA

MOLECULAR AND CELLULAR BIOLOGY, 14(6) 3791-3799, Jun, 1994 Peer-reviewed

Books and Other Publications

最新医学

松崎ゆり子, 河上裕 (Role: Joint author, 287-294)

Sep, 2003

Presentations

PTEN knockout medaka produced by the gene editing technology and its application to screen anticancer drugs

Yuriko Matsuzaki, Hideyuki Saya

第76回日本癌学会学術総会, Sep 28, 2017
PTEN knockout medaka: analysis of the mutated phenotype detected in embryos and its application as a disease model

Yuriko Matsuzaki, Tetsushi Sakuma, Takashi Yamamoto, Hideyuki Saya

第39回日本分子生物学会年会, Nov, 2016
Development of genetically engineered medaka tumor models for in vivo drug screening

Yuriko Matsuzaki, Hideyuki Saya

第74回日本癌学会学術総会, Oct, 2015 Invited
Development of the PTEN knockout medaka embryos by targeted mutagenesis using transcription activator-like effector nucleases (TALENs)

Yuriko Matsuzaki, Tetsushi Sakuma, Takashi Yamamoto, Hideyuki Saya

第37回日本分子生物学会年会, Nov, 2014
Establishment of transgenic HRAS medaka as a tumor model for in vivo drug screening

Yuriko Matsuzaki, Hideyuki Saya

第73回日本癌学会学術総会, Sep, 2014
抗癌剤スクリーニングに用いるための遺伝子導入メダカ腫瘍モデルの確立

Yuriko Matsuzaki

第84回日本動物学会, Sep 21, 2013, 日本動物学会 Invited
Establishment of transgenic medaka as a stable tumor model for in vivo screening of anticancer drugs

Yuriko Matsuzaki, Hideyuki Saya

American Association for Cancer Research Annual Meeting 2013, Apr, 2013
薬剤スクリーニングに用いるメダカ腫瘍モデルの確立

Yuriko Matsuzaki

第5回医学・創薬に向けた小型魚類モデル利用推進ネットワーク, Jan 25, 2013 Invited
HRASG12V transgenic medaka fish develop melanoma with high frequency

Yuriko Matsuzaki, Hideyuki Saya

第70回日本癌学会学術総会, Oct, 2011
New melanoma model using transgenic medaka fish

Yuriko Matsuzaki, Atsushi Shimizu, Hideyuki Saya

第33回日本分子生物学会年会, Dec, 2010
New cancer model using transgenic medaka fish

Yuriko Matsuzaki, Hideyuki Saya

第68回日本癌学会学術総会, Oct, 2009
悪性黒色腫の増殖浸潤に関与する腫瘍抗原の同定

松崎ゆり子, 後藤康文, 油谷浩幸, 斎田俊明, 河上裕

第9回基盤的癌免疫研究会総会, Jul 14, 2005
新規アルゴリズムによるHLA-A24結合性ペプチド予測とHLA-A24トランスジェニックマウスを用いた腫瘍抗原T細胞エピトープの同定

長谷川豪, 塚本真, 松崎ゆり子, 藤田知信, 宮川知也, 河上裕

第9回基盤的癌免疫研究会総会, Jul 14, 2005
シェーグレン症候群患者唾液腺・涙腺を移植したSCIDマウス血清を用いた自己抗原の同定

桜井敏晴, 山本和彦, 松崎ゆり子, 中川洋一, 斎藤一郎, 坪田一男, 河上裕

第34回日本免疫学会総会学術集会, Dec 1, 2004
子宮体癌移植SCIDマウス血清を用いたSEREX

平尾薫丸, 藤田知信, 岩田卓, 岡田勉, 松崎ゆり子, 油谷浩幸, 野澤志朗, 河上裕

第34回日本免疫学会総会学術集会, Dec 1, 2004
DNA chip解析と患者血清スクリーニングによる新規癌精巣抗原の同定

林恵美子, 松崎ゆり子, 藤田知信, 河上裕

第34回日本免疫学会総会学術集会, Dec 1, 2004
Immunogenicity of various human melanoma antigens identified by immunological and genetic methods.

Kawakami Yutaka, Fujita Tomonobu, Matsuzaki Yuriko, Sakurai Toshiharu, Tsukamoto Makoto, Sumimoto Hidetoshi, Go Hasegawa, Udagawa Masaru

International Melanoma Research Congress, Nov 13, 2004 Invited
Identification of a novel cancer-testis antigen frequently expressed in melanoma using representational differential analysis(RDA) and immunodetection with patients’ sera.

Hayashi Emiko, Matsuzaki Yuriko, Fujita Tomonobu, Kawakami Yutaka

International Melanoma Research Congress, Nov 13, 2004
RDA法と患者血清スクリーニングを用いた新規癌精巣抗原の同定

林恵美子, 松崎ゆり子, 藤田知信, 河上裕

第63回日本癌学会学術総会, Sep 29, 2004
MSI陽性子宮体癌患者における抗CAGE抗原の検出

岩田卓, 藤田知信, 平尾薫丸, 鈴木ゆり子, 菅野康吉, 野澤志朗, 河上裕

第63回日本癌学会学術総会, Sep 29, 2004

Professional Memberships

Research Projects

メダカHRAS悪性黒色腫モデルを用いた薬剤スクリーニング系の構築

Grant-in-Aid for Scientific Research, Apr, 2012 - Mar, 2015

松崎ゆり子
遺伝子改変メダカを用いた悪性黒色腫モデル系の構築

Grant-in-Aid for Scientific Research, Apr, 2009 - Mar, 2012

松崎ゆり子
遺伝子改変メダカを用いた分裂異常に基づく発癌モデルの構築

Grant-in-Aid for Scientific Research, Apr, 2008 - Mar, 2009

佐谷秀行
網羅的発現解析で同定した悪性黒色腫高発現遺伝子と病態解析と診断・治療への応用

Grant-in-Aid for Scientific Research, Apr, 2007 - Mar, 2009
DNAチップで同定した悪性黒色腫高発現分子のRNA干渉法による病態解析と臨床応用

Grant-in-Aid for Scientific Research, Apr, 2005 - Mar, 2007

松崎ゆり子
色素異常症の解明に向けたRNA干渉法による色素細胞特異遺伝子の機能解析

Grant-in-Aid for Scientific Research, Apr, 2003 - Mar, 2005

松崎(鈴木)ゆり子

Social Activities

国立科学博物館サイエンスコミュニケータ養成講座1受講及び修了

Jul, 2018 - Present